drugset / Trial / NCT04082598

Antibiotic Therapy in Erupted Tooth Extractions

NCT04082598

Phase 4 Completed 165 enrolled Antonio Barone
RandomizedParallel-groupSingle-blindTreatment

Summary

Evaluation of the efficacy of amox+clav and of a probiotic after tooth extraction. the aim is to evaluate efficacy of antibiotic therapy after tooth extractions in preventing infections as compared to no therapy, and efficacy of probiotics in preventing gastro-intestinal adverse effects during the antibiotic treatment. The number of patients to be included is 150. The study products are: Amoxicillin + Clavulanic Acid and Bifidobacterium Longum and Lactoferrin.

Timeline

Start
2016-10-01
Primary completion
2018-09-30
Completion
2019-01-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Amoxicillin Other / unclassified 875 mg
Subject Amoxicillin Other / unclassified
Subject Bifidobacterium longum Other / unclassified
Subject Lactoferrin Protein / enzyme biologic
Subject clavulanic acid Small molecule 125 mg

Indications

No indication recorded.